Free Trial
LON:N4P

N4 Pharma (N4P) Share Price, News & Analysis

N4 Pharma logo
GBX 0.56 +0.11 (+24.44%)
As of 11:48 AM Eastern

About N4 Pharma Stock (LON:N4P)

Key Stats

Today's Range
0.40
0.70
50-Day Range
0.35
0.56
52-Week Range
0.35
0.80
Volume
18.13 million shs
Average Volume
1.98 million shs
Market Capitalization
£4.66 million
P/E Ratio
N/A
Dividend Yield
3.12%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive N4P Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for N4 Pharma and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

N4P Stock News Headlines

N4 Pharma PLC reports change in major holdings
N4 Pharma PLC
One tiny company just cracked Google’s $19B problem
For decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. Then an MIT team cracked the code… dropping the cost from $63,000 to just 90 cents per gram. Now, one US-based factory is gearing up to supply the AI, aerospace, and EV industries with the one material they can’t continue to grow without. Only one company controls it, and its stock is still flying under Main Street’s radar.tc pixel
N4 Pharma Plc Share Chat (N4P)
N4 Pharma PLC (N4P.AQ)
See More Headlines

N4P Stock Analysis - Frequently Asked Questions

N4 Pharma's stock was trading at GBX 0.54 at the start of the year. Since then, N4P stock has increased by 4.7% and is now trading at GBX 0.56.

N4 Pharma Plc (LON:N4P) released its quarterly earnings data on Monday, June, 9th. The company reported ($0.31) earnings per share (EPS) for the quarter. N4 Pharma had a negative trailing twelve-month return on equity of 90.68% and a negative net margin of 18,399.86%.

Shares of N4P stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that N4 Pharma investors own include 4D pharma (DDDD), Active Energy Group (AEG), B&M European Value Retail (BME), BP (BP), Coats Group (COA), EQTEC (EQT) and genedrive (GDR).

Company Calendar

Last Earnings
6/09/2025
Today
9/01/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
LON:N4P
CIK
N/A
Fax
N/A
Employees
5
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX 0
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£1.63 million
Net Margins
-18,399.86%
Pretax Margin
N/A
Return on Equity
-90.68%
Return on Assets
-56.00%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
22.73
Quick Ratio
7.28

Sales & Book Value

Annual Sales
£7.28 thousand
Price / Sales
640.04
Cash Flow
GBX 0.25 per share
Price / Cash Flow
2.25
Book Value
GBX 0.45 per share
Price / Book
1.25

Miscellaneous

Outstanding Shares
832,280,000
Free Float
N/A
Market Cap
£4.66 million
Optionable
Not Optionable
Beta
-0.37
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (LON:N4P) was last updated on 9/1/2025 by MarketBeat.com Staff
From Our Partners